| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.25B | — | +22.4% |
| Cost of Revenue | $683.9M | — | +18.8% |
| Gross Profit | $564.9M | — | +26.9% |
| R&D Expense | $189.5M | — | +2.7% |
| SG&A Expense | $102.5M | — | +8.4% |
| Operating Income | $51.8M | — | +189.7% |
| Pre-tax Income | $88.6M | — | +318.8% |
| Income Tax | $2.9M | — | +122.5% |
| Net Income | $85.7M | — | +412.4% |
| EPS (Basic) | $0.58 | — | +405.3% |
| EPS (Diluted) | $0.57 | — | +400.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.65B | +4.0% | -26.9% |
| Short-term Investments | $730.3M | +0.0% | — |
| Accounts Receivable | $752.6M | -14.5% | +15.7% |
| Inventory | $101.3M | -11.6% | -25.1% |
| Current Assets | $3.37B | -0.9% | +7.1% |
| Total Assets | $4.35B | -1.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $199.1M | — | +43.5% |
| Capital Expenditures | $3.1M | — | +62.3% |
| Investing Cash Flow | $15.3M | — | +270.9% |
| Financing Cash Flow | -$149.7M | — | -315.1% |
| Free Cash Flow | $196.0M | — | +43.3% |
| +4.1% |
| Current Liabilities | $1.16B | -6.4% | +5.4% |
| Total Liabilities | $1.68B | -5.3% | +1.7% |
| Stockholders' Equity | $2.67B | +0.5% | +5.8% |